CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo

CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo

Current strategies for glioma treatment are only partly effective because of the poor selectivity for tumoral cells. Hence, the necessity to identify novel approaches is urgent. Recent studies highlighted the effectiveness of the bacterial protein cytotoxic necrotizing factor 1 (CNF1) in reducing tu...

Full description

Bibliographic Details
Main Authors: Eleonora Vannini, Elisabetta Mori, Elena Tantillo, Gudula Schmidt, Matteo Caleo, Mario Costa
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Toxins
Subjects:
glioblastoma
drug discovery
cytotoxic necrotizing factor type 1
chlorotoxin
recombinant protein production
glioma
Online Access:https://www.mdpi.com/2072-6651/13/3/194

Similar Items

Similar Items